Touchlight Appoints Industry Leader Will Downie as Adviser to Support Strategic Growth in Synthetic DNA Platforms Published: 27 January 2025 Touchlight Genetics, in partnership with the National Physical Laboratory (NPL)…
Read More
Ceva Animal Health and Touchlight sign an agreement to use Touchlight’s dbDNA technology in animal health Published: 16 January 2025 Ceva and Touchlight entered into an agreement and a long-term…
Read More
Touchlight’s dbDNA™ manufacturing facility receives world-first GMP license from MHRA Published: 14 January 2025 Touchlight’s dbDNA technology is the first synthetic DNA technology to receive a GMP certificate globally Touchlight…
Read More
Touchlight to supply GMP dbDNA to support University of Nottingham’s clinical study for a next-generation vaccine for Zika virus Published: 21 August 2024 Touchlight, an innovation-driven contract development and manufacturing…
Read More
Touchlight and GSK sign license agreement for use of enzymatic dbDNA production technology for mRNA manufacturing Published: 23 July 2024 Agreement enables GSK access to enzymatic production technology for rapid…
Read More
Touchlight and LenioBio collaborate to accelerate development of protein therapeutics for pandemic response Published: 2 July 2024 Touchlight to participate in LenioBio’s recently announced grant from CEPI 02 July, HAMPTON,…
Read More
Touchlight Genetics and the National Physical Laboratory (NPL) awarded grant to develop novel gene-length single-stranded genome editing template. Published: 9 May 2024 Touchlight Genetics, in partnership with the National Physical…
Read More
Touchlight awarded grant extension to further develop DNA-enabled Biobatteries with U.S. Office for Naval Research and UK Defence Science & Technology Laboratory Published: 26 April 2024 Touchlight, a biotechnology CDMO…
Read More
University of Liverpool to use Touchlight’s rapid enzymatic dbDNA in fully personalised neoantigen cancer vaccine clinical study Published: 4 April 2024 The UK’s Medical Research Council is funding a 10-patient…
Read More
Touchlight awarded tender to supply enzymatic dbDNA to CPI’s RNA Centre of Excellence Published: 28 March 2024 Touchlight, an innovation-driven CDMO enabling the development of genetic medicines with its doggybone…
Read More
